Filter
14
Filtered Results: 14
Text search:
D.
K.
Mubangizi
Featured
New Publications
5
Language
Document type
No document type
8
Studies & Reports
3
Manuals
2
Guidelines
1
Countries / Regions
Uganda
3
South Africa
2
Kenya
1
Congo, Democratic Republic of
1
Mali
1
Botswana
1
South Sudan
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Studies & Reports
4
Women & Child Health
2
Hepatitis
1
Family Planning
1
Policies
1
Guidelines
1
Capacity Building
1
Other
1
Quality Control & Assurance
1
Reproductive Health
1
Toolboxes
Africa
1
Clinical Aspects, Treatment & Prevention
1
Essential Medicines
1
Prices and Patents
1
Zoonoses
1
Clinical Aspects & Diagnostics
1
General
1
Antiretroviral Treatment ART
1
THEME: TEENAGE PREGNANCY AN OBSTACLE TO MATERNAL HEALTH; LET US STOP IT NOW. 5th November 2013
Conclusion: To ensure that people with disabilities can successfully access the necessary health services, the barriers on the demand side (the individuals requiring healthcare) as well as the barriers that are part of the healthcare system, should be attended to.
2nd edition - Published in 2003, the first WHO/HAI medicine prices manual Medicine Prices – A
New Approach to Measurement Draft for field-testing provides a draft methodology and tools to conduct national medicine prices and availability surveys. This second edition of the survey manual has been...
This checklist covers five areas of competence needed by health care providers to provide quality of care in contraceptive information and services including: respecting users’ privacy and guaranteeing contfidentiality, choice, accessible and acceptable services, involvement of users in improving ...
Session V: Regulatory & quality assurance aspects
Update on prequalification of ARVs and regional harmonisation of medicine registration
Deusdedit K. Mubangizi
Group Lead, Inspections, WHO-PQT E-mail: mubangizid@who.int
Acknowledgements:
• Matthias Stahl
• Milan Smid
• Antony Fake
...
Journal of the International AIDS Society 2016, 19:20926
There is a growing interest in the potential contribution the private sector can make towards increasing access to antiretroviral therapy (ART) in low‐ and middle‐income settings. This article describes a public–private partnership ...
There is a growing interest in the potential contribution the private sector can make towards increasing access to antiretroviral therapy (ART) in low‐ and middle‐income settings. This article describes a public–private partnership ...
BMC Public Health (2019) 19:1608
https://doi.org/10.1186/s12889-019-7853-3
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha...
Clinical Microbiology and Infection Volume 21, Issue 5, May 2015, Pages 433-443;
The neglected zoonotic diseases (NZDs) have been all but eradicated in wealthier countries, but remain major causes of ill-health and mortality across Africa, Asia, and Latin America. This neglect is, in part, a conse...
Female Genital Schistosomiasis (FGS) is a gynaecological disease caused by Schistosoma haematobium, a parasitic worm that is acquired by skin contact with freshwater contaminated by schistosome cerceriae. Communities in which the infection is most endemic have limited access to clean water and healt...
